Liliana Torres-López

6PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 14, 2026
Pharmacological Modulation of Autophagy Can Sensitize Acute Lymphoblastic Leukemia Cell Lines to Dexamethasone.

Liliana Torres-López, Miguel Olivas-Aguirre, Alejandro Chávez-Gutiérrez

|Oct 27, 2023
Dissecting the Role of Autophagy-Related Proteins in Cancer Metabolism and Plasticity.

Liliana Torres-López, Oxana Dobrovinskaya

|Jan 21, 2023
Dexamethasone-Induced Fatty Acid Oxidation and Autophagy/Mitophagy Are Essential for T-ALL Glucocorticoid Resistance.

Miguel Olivas-Aguirre, Jesús Pérez-Chávez, Liliana Torres-López

|Mar 26, 2022
Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges.

Miguel Olivas-Aguirre, Liliana Torres-López, Kathya Villatoro-Gómez

|Aug 27, 2021
Tamoxifen Sensitizes Acute Lymphoblastic Leukemia Cells to Cannabidiol by Targeting Cyclophilin-D and Altering Mitochondrial Ca2+ Homeostasis.

Miguel Olivas-Aguirre, Liliana Torres-López, Zeferino Gómez-Sandoval

|Dec 31, 2020
Phenolic Compounds Cannabidiol, Curcumin and Quercetin Cause Mitochondrial Dysfunction and Suppress Acute Lymphoblastic Leukemia Cells.

Miguel Olivas-Aguirre, Liliana Torres-López, Igor Pottosin

Pageof 1